These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29752214)

  • 1. Evaluation of pneumococcal and influenza vaccination coverage in rheumatology patients receiving biological therapy in a regional referral hospital.
    Fernández-Prada M; Brandy-García AM; Rodríguez-Fonseca OD; Huerta-González I; Fernández-Noval F; Martínez-Ortega C
    Reumatol Clin (Engl Ed); 2020; 16(2 Pt 1):97-102. PubMed ID: 29752214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Coverage With Influenza, Pneumococcal, and Herpes Zoster Vaccines Among Patients With Rheumatic Diseases in a Nationwide Healthcare Plan.
    Furer V; Weil C; Chodik G; Slav SA; Blonder SN; Fisher-Shoval Y; Barak M; Elkayam O
    J Rheumatol; 2024 May; 51(5):505-516. PubMed ID: 38302167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against influenza and pneumococcal infections in patients with autoimmune disorders under biological therapy: Coverage and attitudes in patients and physicians.
    Lejri-El Euchi H; Chirpaz E; Foucher A; Sultan-Bichat N; Randrianjohany A; Poubeau P; Gamon E; Roussin C; Osdoit S; Raffray L
    Eur J Intern Med; 2019 Nov; 69():25-31. PubMed ID: 31445784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017.
    Vila-Córcoles A; Ochoa-Gondar O; de Diego C; Satué E; Vila-Rovira A; Aragón M
    Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of vaccination coverage in cochlear implant patients at a referral hospital in Northern Spain.
    Fernández-Prada M; Madroñal-Menéndez J; Martínez-Ortega C; Ramos-Martín P; Fernández-Noval F; Huerta-González I; Llorente-Pendás JL; Gómez-Martínez JR
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(6):336-341. PubMed ID: 30579509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.
    Nakashima K; Aoshima M; Ohfuji S; Yamawaki S; Nemoto M; Hasegawa S; Noma S; Misawa M; Hosokawa N; Yaegashi M; Otsuka Y
    Hum Vaccin Immunother; 2018; 14(8):1923-1930. PubMed ID: 29561248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial.
    Thompson AR; Klein NP; Downey HJ; Patterson S; Sundaraiyer V; Watson W; Clarke K; Jansen KU; Sebastian S; Gruber WC; Scott DA; Schmöele-Thoma B
    Hum Vaccin Immunother; 2019; 15(2):444-451. PubMed ID: 30303436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.
    Cho BH; Stoecker C; Link-Gelles R; Moore MR
    Vaccine; 2013 Dec; 31(50):6011-21. PubMed ID: 24148572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017.
    Wang Y; Cheng M; Wang S; Wu F; Yan Q; Yang Q; Li Y; Guo X; Fu C; Shi Y; Wagner AL; Boulton ML
    BMC Public Health; 2020 Mar; 20(1):359. PubMed ID: 32188428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA).
    Nguyen M; Lindegaard H; Hendricks O; Friis-Møller N
    Scand J Rheumatol; 2017 Nov; 46(6):446-453. PubMed ID: 28145151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group.
    Svensson T; Kättström M; Hammarlund Y; Roth D; Andersson PO; Svensson M; Nilsson I; Rombo L; Cherif H; Kimby E
    Vaccine; 2018 Jun; 36(25):3701-3707. PubMed ID: 29748028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: A retrospective study.
    Brocq O; Acquacalda E; Berthier F; Albert C; Bolla G; Millasseau E; Destombe C; Azulay J; Asquier C; Florent A; Le Seaux S; Euller-Ziegler L
    Joint Bone Spine; 2016 Mar; 83(2):155-9. PubMed ID: 26725745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a seasonal influenza and a pneumococcal polysaccharide vaccine in multiple sclerosis patients under disease modifying therapies: A single-center prospective study.
    Marantos T; Kyriazopoulou E; Angelakis E; Kitsos D; Chondrogianni M; Mpizta G; Papadopoulos A; Giannopoulos S; Voumvourakis K; Tsiodras S
    Vaccine; 2024 Sep; 42(22):126001. PubMed ID: 38796324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
    Benedict Kpozehouen E; Macintyre CR; Tan TC
    Vaccine; 2024 May; 42(15):3404-3409. PubMed ID: 38704255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal vaccination coverage at the initiation of chronic dialysis, and its association with mortality during the first year.
    Pierre É; Pladys A; Bayat-Makoei S; Tattevin P; Vigneau C
    Vaccine; 2023 Jun; 41(24):3655-3662. PubMed ID: 37179164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults.
    Schmoele-Thoma B; van Cleeff M; Greenberg RN; Gurtman A; Jones TR; Sundaraiyer V; Gruber WC; Scott DA
    Hum Vaccin Immunother; 2019; 15(3):575-583. PubMed ID: 30648932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
    Loubet P; Kernéis S; Groh M; Loulergue P; Blanche P; Verger P; Launay O
    Vaccine; 2015 Jul; 33(31):3703-8. PubMed ID: 26073016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.
    Alten R; Bingham CO; Cohen SB; Curtis JR; Kelly S; Wong D; Genovese MC
    BMC Musculoskelet Disord; 2016 May; 17():231. PubMed ID: 27229685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indicators of influenza and pneumococcal vaccination in French nursing home residents in 2011.
    de Souto Barreto P; Lapeyre-Mestre M; Vellas B; Rolland Y
    Vaccine; 2014 Feb; 32(7):846-51. PubMed ID: 24370710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea.
    Heo JY; Seo YB; Choi WS; Lee J; Noh JY; Jeong HW; Kim WJ; Kim MJ; Lee HY; Song JY
    PLoS One; 2017; 12(5):e0177342. PubMed ID: 28498857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.